|
US502504A
(en)
|
|
1893-08-01 |
|
Hermann thoms |
|
US1792156A
(en)
|
1928-01-17 |
1931-02-10 |
Gen Aniline Works Inc |
5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
|
|
US2093265A
(en)
*
|
1931-03-31 |
1937-09-14 |
Ici Ltd |
Process for the manufacture of diaryl ureas
|
|
US2046375A
(en)
|
1931-06-04 |
1936-07-07 |
Ici Ltd |
p-halogen-omicron-alkoxy-aniline derivatives and process of preparing the same
|
|
US2288422A
(en)
*
|
1938-11-11 |
1942-06-30 |
Gen Aniline & Film Corp |
Mixed ureas
|
|
US2973386A
(en)
*
|
1943-01-05 |
1961-02-28 |
Harry A Weldon |
Purification of sym dichloro-bis (2, 4, 6-trichlorophenyl)urea
|
|
DE925476C
(de)
*
|
1950-04-29 |
1955-03-21 |
Variapat Ag |
Verfahren zur Herstellung von farblosen, wasserloeslichen, trifluormethyl- und sulfonsaeuregruppenhaltigen, aliphatischen oder aromatischen Carbonsaeure- bzw. Sulfonsaeurearyliden
|
|
US2683082A
(en)
*
|
1950-12-09 |
1954-07-06 |
Ethyl Corp |
Nu-aryl-nu'-(p-hydroxyphenyl) ureas as antioxidants for petroleum hydrocarbon fuels
|
|
US2722544A
(en)
*
|
1950-12-26 |
1955-11-01 |
Variapat Ag |
Trifluoromethyl halogenated diphenylcarbamide sulfonic acids and their preparation
|
|
US2781330A
(en)
|
1953-02-09 |
1957-02-12 |
Monsanto Chemicals |
Rubber containing urea compound as an anti-exposure cracking agent
|
|
NL185660B
(nl)
*
|
1953-03-06 |
|
Great Lakes Chemical Corp |
Werkwijze voor het bereiden van alkali- of aardalkalimetaalbromiden.
|
|
US2745874A
(en)
|
1953-06-18 |
1956-05-15 |
Geigy Ag J R |
Insecticidal derivatives of diphenyl urea
|
|
NL193403A
(enExample)
|
1953-12-22 |
1924-02-17 |
|
|
|
GB771333A
(en)
|
1953-12-22 |
1957-03-27 |
Geigy Ag J R |
Improvements relating to halogen substituted diphenyl urea and thiourea compounds and their use
|
|
GB828231A
(en)
|
1955-10-20 |
1960-02-17 |
Geigy Ag J R |
Improvements relating to insecticidal compounds and their use
|
|
US2877268A
(en)
*
|
1956-12-24 |
1959-03-10 |
Monsanto Chemicals |
Substituted ureas
|
|
US2960488A
(en)
*
|
1958-04-25 |
1960-11-15 |
Eastman Kodak Co |
Poly-alpha-olefins containing substituted ureas
|
|
NL254871A
(enExample)
|
1959-08-14 |
|
|
|
|
NL277504A
(enExample)
*
|
1961-04-21 |
|
|
|
|
CH479557A
(de)
|
1961-09-11 |
1969-10-15 |
Wander Ag Dr A |
Verfahren zur Herstellung neuer mehrbasischer Verbindungen
|
|
US3200035A
(en)
|
1962-06-01 |
1965-08-10 |
Ciba Ltd |
Treatment of synthetic products, especially synthetic fibers
|
|
US3284433A
(en)
|
1963-07-17 |
1966-11-08 |
Merck & Co Inc |
4-phenoxy-carbanilides
|
|
FR1457172A
(fr)
|
1964-12-12 |
1966-10-28 |
Ferrania Spa |
Procédé pour la production d'images photographiques en couleurs et matériel photographique correspondant
|
|
FR90420E
(enExample)
|
1965-06-09 |
1968-02-21 |
|
|
|
US3424761A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
|
US3424760A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
|
US3424762A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
|
US3547940A
(en)
|
1967-10-31 |
1970-12-15 |
Du Pont |
Substituted ureido isoxazoles
|
|
US3743498A
(en)
|
1967-10-31 |
1973-07-03 |
Du Pont |
Method of selectively controlling undesirable vegetation
|
|
SE370866B
(enExample)
|
1968-03-21 |
1974-11-04 |
Ciba Geigy Ag |
|
|
DE1768244A1
(de)
|
1968-04-19 |
1971-10-14 |
Bayer Ag |
N-(2,2,4,4-Tetrafluor-1,3-benz-dioxanyl)-harnstoffe und Verfahren zu ihrer Herstellung
|
|
US3646059A
(en)
|
1969-05-05 |
1972-02-29 |
Du Pont |
Plant growth regulatory ureidopyrazoles
|
|
US3754887A
(en)
|
1969-05-05 |
1973-08-28 |
Du Pont |
Ureidopyrazoles defoliants
|
|
US3668222A
(en)
*
|
1969-05-14 |
1972-06-06 |
Sandoz Ltd |
11-desacetoxy-wortmannin
|
|
BE754782A
(fr)
|
1969-08-14 |
1971-02-12 |
May & Baker Ltd |
Derives du thiophene a action herbicide
|
|
US3823161A
(en)
|
1970-05-07 |
1974-07-09 |
Exxon Research Engineering Co |
Aminothiophene derivatives
|
|
US3860645A
(en)
*
|
1973-05-23 |
1975-01-14 |
Givaudan Corp |
Bacteriostatic substituted carbanilides
|
|
US4212981A
(en)
*
|
1973-07-27 |
1980-07-15 |
Shionogi & Co., Ltd. |
Process for preparing 3-isoxazolylurea derivatives
|
|
JPS5031039A
(enExample)
|
1973-07-27 |
1975-03-27 |
|
|
|
US4062861A
(en)
|
1973-07-27 |
1977-12-13 |
Shionogi & Co., Ltd. |
3-Isoxazolylurea derivatives
|
|
US4116671A
(en)
*
|
1973-07-27 |
1978-09-26 |
Shionogi & Co., Ltd. |
3-Isoxazolylcarbamate derivatives
|
|
US4001256A
(en)
|
1973-12-26 |
1977-01-04 |
The Upjohn Company |
Pyridylalkyl phenyl ureas and their n-oxides
|
|
US3931201A
(en)
|
1974-01-22 |
1976-01-06 |
The Dow Chemical Company |
Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
|
|
US4009847A
(en)
*
|
1974-04-17 |
1977-03-01 |
E. I. Du Pont De Nemours And Company |
1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents
|
|
US3990879A
(en)
|
1974-12-26 |
1976-11-09 |
Eli Lilly And Company |
Method of controlling aquatic weeds
|
|
US4111683A
(en)
*
|
1975-06-27 |
1978-09-05 |
Chevron Research Company |
N-alkyl or alkoxy-N'-substituted hydrocarbyl urea
|
|
DE2637947C2
(de)
|
1976-08-24 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Tetrafluor-1,3-benzodioxanyl-benzoylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
|
|
US4173637A
(en)
*
|
1976-10-29 |
1979-11-06 |
Ishihara Sangyo Kaisha Ltd. |
N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof
|
|
JPS5840946B2
(ja)
*
|
1976-10-29 |
1983-09-08 |
石原産業株式会社 |
Ｎ−ベンゾイル−ｎ′−ピリジルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する殺虫剤
|
|
US4071524A
(en)
|
1976-11-08 |
1978-01-31 |
Riker Laboratories, Inc. |
Derivatives of urea
|
|
US4183854A
(en)
*
|
1976-11-10 |
1980-01-15 |
John Wyeth & Brother Limited |
Thiazole compound
|
|
US4042372A
(en)
*
|
1976-11-19 |
1977-08-16 |
Eli Lilly And Company |
Substituted thiadiazolotriazinediones and method of preparation
|
|
DE2817449A1
(de)
|
1978-04-21 |
1979-10-31 |
Bayer Ag |
Mittel zur regulierung des pflanzenwachstums
|
|
GB1590870A
(en)
|
1978-05-31 |
1981-06-10 |
Shionogi & Co |
N-(5-t-butyl-3-isoxazolyl) alkanamide derivatives having herbicidal activity
|
|
JPS5562066A
(en)
*
|
1978-11-03 |
1980-05-10 |
Toshihiko Okamoto |
N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
|
|
DE2848330A1
(de)
|
1978-11-03 |
1980-05-14 |
Schering Ag |
Verfahren zur herstellung von 1,2, 3-thiadiazol-5-yl-harnstoffen
|
|
FI800559A7
(fi)
|
1979-03-14 |
1981-01-01 |
F Hoffmann La Roche & Co |
Virtsa-ainejohdannaiset.
|
|
JPS55124763A
(en)
*
|
1979-03-19 |
1980-09-26 |
Ishihara Sangyo Kaisha Ltd |
5-trifluoromethyl-2-pyridone derivative
|
|
DE2928485A1
(de)
*
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
US4468380A
(en)
*
|
1979-12-26 |
1984-08-28 |
Eli Lilly And Company |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
|
CH649078A5
(de)
*
|
1980-01-25 |
1985-04-30 |
Reanal Finomvegyszergyar |
Verfahren zur herstellung von n-mono- oder disubstituierten n-aryl-harnstoff-derivaten.
|
|
EP0057797B1
(en)
|
1981-02-03 |
1986-06-25 |
Imperial Chemical Industries Plc |
Process for the extraction of metal values and novel metal extractants
|
|
US4526997A
(en)
|
1981-05-06 |
1985-07-02 |
Doherty George O P O |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
|
US4511571A
(en)
|
1981-10-20 |
1985-04-16 |
Ciba Geigy Corporation |
N-(2-Pyridyloxyphenyl)-N'-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use
|
|
US4623662A
(en)
|
1985-05-23 |
1986-11-18 |
American Cyanamid Company |
Antiatherosclerotic ureas and thioureas
|
|
US4473579A
(en)
*
|
1982-01-26 |
1984-09-25 |
American Cyanamid Company |
Antiatherosclerotic tetrasubstituted ureas and thioureas
|
|
DE3211851A1
(de)
*
|
1982-03-31 |
1983-10-06 |
Basf Ag |
Dihydrothiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
|
JPS58203957A
(ja)
*
|
1982-05-25 |
1983-11-28 |
Ube Ind Ltd |
尿素誘導体の製法
|
|
IL69621A0
(en)
|
1982-09-02 |
1983-12-30 |
Duphar Int Res |
Pharmaceutical compositions having antitumor activity,comprising certain phenylurea derivatives
|
|
CA1254212A
(en)
|
1982-11-12 |
1989-05-16 |
Shiro Hirai |
Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
|
|
DE3305866A1
(de)
|
1983-02-19 |
1984-08-23 |
Basf Ag, 6700 Ludwigshafen |
Thiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
|
US4499097A
(en)
*
|
1983-03-10 |
1985-02-12 |
American Cyanamid Company |
2-(Pyridyl)imidazolyl ketones
|
|
GB8325496D0
(en)
|
1983-09-23 |
1983-10-26 |
Hider R C |
Pharmaceutical compositions
|
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
|
JPS6193163A
(ja)
*
|
1984-10-12 |
1986-05-12 |
Ishihara Sangyo Kaisha Ltd |
Ｎ−ベンゾイル−ｎ′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤
|
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
|
DE3529247A1
(de)
|
1985-05-17 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
|
|
DE3540377A1
(de)
|
1985-11-14 |
1987-05-21 |
Bayer Ag |
Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
|
|
DE3541631A1
(de)
|
1985-11-26 |
1987-05-27 |
Bayer Ag |
Selektiv-fungizide verwendung von thienylharnstoff-derivaten
|
|
AU594098B2
(en)
|
1985-12-11 |
1990-03-01 |
Ishihara Sangyo Kaisha Ltd. |
N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
|
|
EP0230400A3
(de)
|
1986-01-21 |
1990-02-14 |
Ciba-Geigy Ag |
N-3-(5-Trifluormethyl-pyridyl-2-oxy)-phenyl-N'-benzoylharnstoffe zur Bekämpfung von Helminthen an Nutztieren
|
|
JPS62185013A
(ja)
|
1986-02-08 |
1987-08-13 |
Green Cross Corp:The |
易吸収性医薬組成物
|
|
DE3612830A1
(de)
|
1986-04-16 |
1987-10-22 |
Basf Ag |
Thiadiazolylharnstoff enthaltendes mittel zur entblaetterung von pflanzen
|
|
EP0255297B1
(en)
|
1986-07-31 |
1993-04-21 |
Beecham Group Plc |
Azabicyclic compounds, process for their preparation, and their pharmaceutical use
|
|
NZ221964A
(en)
|
1986-10-03 |
1990-03-27 |
Ishihara Sangyo Kaisha |
Benzoylurea compounds and insecticidal compositions
|
|
EP0264904A3
(en)
|
1986-10-23 |
1988-08-17 |
Ishihara Sangyo Kaisha, Ltd. |
Pharmaceutical compositions containing benzoyl urea derivatives
|
|
DE3636190A1
(de)
|
1986-10-24 |
1988-04-28 |
Bayer Ag |
Verfahren zur herstellung von n,n-diaryl-harnstoffen
|
|
JPH06100808B2
(ja)
|
1987-05-28 |
1994-12-12 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
ES2070861T3
(es)
|
1987-10-16 |
1995-06-16 |
Ciba Geigy Ag |
Compuestos antiparasitarios.
|
|
DE3810382A1
(de)
|
1988-03-26 |
1989-10-12 |
Bayer Ag |
5-amino-1-phenylpyrazole, verfahren sowie 5-halogen-1-phenylpyrazole als zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
|
|
JP2791156B2
(ja)
|
1988-08-23 |
1998-08-27 |
ザ ヌトラスウィート カンパニー |
強力甘味料としての置換アリール尿素
|
|
JPH0278699A
(ja)
|
1988-09-12 |
1990-03-19 |
Green Cross Corp:The |
ベンゾイルウレア系化合物・アルブミン複合体
|
|
FR2639636B1
(fr)
|
1988-11-30 |
1994-03-04 |
Novapharme |
Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
|
|
FR2662692B1
(fr)
|
1990-05-30 |
1995-04-28 |
Novapharme |
Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
|
|
JPH02237922A
(ja)
|
1989-01-24 |
1990-09-20 |
Green Cross Corp:The |
抗ウィルス剤
|
|
JPH02196719A
(ja)
|
1989-01-24 |
1990-08-03 |
Green Cross Corp:The |
粉末状医薬組成物
|
|
EP0379915A1
(de)
|
1989-01-26 |
1990-08-01 |
Bayer Ag |
Substituierte Phenoxybenzonitril-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwuchsregulatoren
|
|
JP3002204B2
(ja)
|
1989-03-13 |
2000-01-24 |
株式会社東芝 |
時系列信号認識装置
|
|
US4973675A
(en)
|
1989-04-13 |
1990-11-27 |
University Of Tennessee Research Center |
Hybrid nitrosoureidoanthracyclines having antitumor activity
|
|
JPH0395153A
(ja)
|
1989-06-15 |
1991-04-19 |
Mitsubishi Kasei Corp |
ジフェニル尿素誘導体
|
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
|
IL95860A0
(en)
|
1989-10-13 |
1991-07-18 |
Ciba Geigy Ag |
Thienylthioureas,-isothioureas and-carbodiimides
|
|
EP0425443A1
(de)
|
1989-10-27 |
1991-05-02 |
Ciba-Geigy Ag |
Injizierbares parasitizides Mittel
|
|
US5177110A
(en)
|
1989-10-27 |
1993-01-05 |
Ciba-Geigy Corporation |
Injectable parasiticidal composition
|
|
CN1034934C
(zh)
|
1990-06-19 |
1997-05-21 |
明治制果株式会社 |
血管紧张素ii拮抗性吡啶衍生物的制备方法
|
|
US5210015A
(en)
|
1990-08-06 |
1993-05-11 |
Hoffman-La Roche Inc. |
Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
|
|
GB9017892D0
(en)
|
1990-08-15 |
1990-09-26 |
May & Baker Ltd |
New compositions of matter
|
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
|
EP0525197B1
(en)
|
1991-01-21 |
1997-08-27 |
Shionogi Seiyaku Kabushiki Kaisha |
3-benzylidene-1-carbamoyl-2-pyrrolidone analogs
|
|
JP2671693B2
(ja)
|
1991-03-04 |
1997-10-29 |
松下電器産業株式会社 |
バイオセンサおよびその製造法
|
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
|
US5185438A
(en)
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
|
US5100883A
(en)
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
|
US5118678A
(en)
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
|
NO921449L
(no)
|
1991-04-17 |
1992-10-19 |
American Home Prod |
Karbamater av rapamycin
|
|
US5721237A
(en)
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
|
US5118677A
(en)
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
|
US5185358A
(en)
|
1991-06-24 |
1993-02-09 |
Warner-Lambert Co. |
3-heteroatom containing urea and thiourea ACAT inhibitors
|
|
WO1993004170A1
(en)
|
1991-08-23 |
1993-03-04 |
The United States Of America Represented By The Secretary, Department Of Health And Human Services |
Raf protein kinase therapeutics
|
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
|
WO1993009128A1
(en)
|
1991-11-07 |
1993-05-13 |
Nanotronics, Inc. |
Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
|
|
FR2683818B1
(fr)
|
1991-11-14 |
1993-12-31 |
Adir Cie |
Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
US5348853A
(en)
|
1991-12-16 |
1994-09-20 |
Biotronics Corporation |
Method for reducing non-specific priming in DNA amplification
|
|
US5508288A
(en)
|
1992-03-12 |
1996-04-16 |
Smithkline Beecham, P.L.C. |
Indole derivatives as 5HT1C antagonists
|
|
DE4212407A1
(de)
|
1992-04-13 |
1993-10-14 |
Knorr Bremse Gmbh |
Lüftspieldetektor für eine druckluftbetätigte Scheibenbremse
|
|
US5312820A
(en)
|
1992-07-17 |
1994-05-17 |
Merck & Co., Inc. |
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
|
|
ZA935112B
(en)
|
1992-07-17 |
1994-02-08 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
|
ZA935111B
(en)
|
1992-07-17 |
1994-02-04 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
|
KR950702994A
(ko)
|
1992-08-12 |
1995-08-23 |
로렌스 티. 웰츠 |
탁솔과 복합된, 단백질 키나제 억제제 및 관련 화합물(protein kinase inhibitors and related compounds combined with taxol)
|
|
US5256790A
(en)
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
|
JP2717481B2
(ja)
|
1992-08-25 |
1998-02-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
|
EP0672187A4
(en)
|
1992-10-08 |
1999-11-17 |
Univ California |
PCR TEST METHOD FOR DETERMINING PRESENCE AND CONCENTRATING A TARGET SUBSTANCE.
|
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
|
WO1994014801A1
(en)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
|
|
US5512473A
(en)
|
1993-01-29 |
1996-04-30 |
Brent; Roger |
Max-interacting proteins and related molecules and methods
|
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
|
TW272942B
(enExample)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
|
DK41193D0
(da)
|
1993-04-07 |
1993-04-07 |
Neurosearch As |
Ionkanalaabnere
|
|
AU6633694A
(en)
|
1993-04-09 |
1994-11-08 |
Board Of Regents Of The University Of Nebraska, The |
Novel methods and compositions for the treatment of (ras)-activated cancer with heterotypic anti-(raf) antisense oligonucleotides
|
|
GB9308802D0
(en)
|
1993-04-28 |
1993-06-09 |
Smithkline Beecham Plc |
Treatment
|
|
DE4322806A1
(de)
|
1993-07-08 |
1995-01-12 |
Janich Gmbh & Co |
Vorrichtung zur Abdichtung zwischen zwei Anlagenteilen
|
|
IL110296A
(en)
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
|
US6514745B1
(en)
|
1993-07-19 |
2003-02-04 |
The Regents Of The University Of California |
Oncoprotein protein kinase
|
|
US5378725A
(en)
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
|
NZ264063A
(en)
|
1993-08-13 |
1995-11-27 |
Nihon Nohyaku Co Ltd |
N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
|
|
US5441947A
(en)
|
1993-08-25 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting vascular restenosis
|
|
US5468773A
(en)
|
1993-08-25 |
1995-11-21 |
Eli Lilly And Company |
Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
|
|
ATE186551T1
(de)
|
1993-09-17 |
1999-11-15 |
Smithkline Beecham Corp |
Medikamente bindendes protein
|
|
US5869043A
(en)
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
|
US6361773B1
(en)
|
1993-09-17 |
2002-03-26 |
Smithkline Beecham Corporation |
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
|
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
|
CA2133815A1
(en)
|
1993-10-12 |
1995-04-13 |
Jeffrey Alan Dodge |
Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
|
|
US5596001A
(en)
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
|
DE69433501T2
(de)
|
1993-11-08 |
2004-11-04 |
Smithkline Beecham Corp. |
Oxazole zur behandlung von zytokinvermittelten erkrankungen
|
|
US5538848A
(en)
|
1994-11-16 |
1996-07-23 |
Applied Biosystems Division, Perkin-Elmer Corp. |
Method for detecting nucleic acid amplification using self-quenching fluorescence probe
|
|
JPH07141053A
(ja)
|
1993-11-17 |
1995-06-02 |
Nec Niigata Ltd |
クロック発生回路
|
|
EP0729471A1
(en)
|
1993-11-19 |
1996-09-04 |
Abbott Laboratories |
Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
|
|
NZ277498A
(en)
|
1993-12-17 |
1998-03-25 |
Novartis Ag |
Rapamycin derivatives
|
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
|
CH686211A5
(de)
|
1994-01-27 |
1996-02-15 |
Ciba Geigy Ag |
Motten- und Koferschutzmittel.
|
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
|
US6811779B2
(en)
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
|
DE4412334A1
(de)
|
1994-04-11 |
1995-10-19 |
Hoechst Ag |
Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
US5871918A
(en)
|
1996-06-20 |
1999-02-16 |
The University Of North Carolina At Chapel Hill |
Electrochemical detection of nucleic acid hybridization
|
|
EP0706649B1
(en)
|
1994-04-29 |
2001-01-03 |
Perkin-Elmer Corporation |
Method and apparatus for real time detection of nucleic acid amplification products
|
|
US5559137A
(en)
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
|
US5744362A
(en)
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
|
US5563255A
(en)
*
|
1994-05-31 |
1996-10-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
|
US5656612A
(en)
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
|
US5447957A
(en)
|
1994-06-02 |
1995-09-05 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
|
WO1995033458A1
(en)
|
1994-06-02 |
1995-12-14 |
Smithkline Beecham Corporation |
Anti-inflammatory compounds
|
|
US5470882A
(en)
|
1994-06-02 |
1995-11-28 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
|
US5786362A
(en)
|
1994-06-16 |
1998-07-28 |
University Of Miami |
Method of treating Hormone independent cancer
|
|
EP0690344A1
(en)
|
1994-06-29 |
1996-01-03 |
Konica Corporation |
Silver halide color photographic light-sensitive material
|
|
US5480906A
(en)
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
|
FR2722319B1
(fr)
|
1994-07-08 |
1996-08-14 |
Thomson Csf |
Dispositif de visualisation couleurs
|
|
US5597719A
(en)
|
1994-07-14 |
1997-01-28 |
Onyx Pharmaceuticals, Inc. |
Interaction of RAF-1 and 14-3-3 proteins
|
|
DK0708085T3
(da)
|
1994-10-19 |
2002-11-11 |
Novartis Ag |
Antivirale ethere af aspartatproteasesubstrat-isostere
|
|
JP3591938B2
(ja)
|
1994-10-27 |
2004-11-24 |
キヤノン株式会社 |
インクジェット用記録媒体及びこれを用いた画像形成方法
|
|
CA2161376C
(en)
|
1994-10-27 |
2005-01-11 |
Toshiaki Minami |
Reversible multi-color thermal recording medium
|
|
DE69520951T2
(de)
|
1994-10-28 |
2001-11-22 |
Novozymes A/S, Bagsvaerd |
Verfahren zur chemischen ausrüstung von unlöslichen polymerfasern
|
|
US5723290A
(en)
|
1994-11-03 |
1998-03-03 |
Trustees Of The University Of Pennsylvania |
Methods for profiling mRNA expression in neurites
|
|
TW313568B
(enExample)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
EP0809492A4
(en)
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
US5814646A
(en)
|
1995-03-02 |
1998-09-29 |
Eli Lilly And Company |
Inhibitors of amyloid beta-protein production
|
|
US5624937A
(en)
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
|
DE19512639A1
(de)
|
1995-04-05 |
1996-10-10 |
Merck Patent Gmbh |
Benzonitrile und -fluoride
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
|
US5773459A
(en)
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
|
KR100400620B1
(ko)
|
1995-06-09 |
2004-02-18 |
노파르티스 아게 |
라파마이신유도체
|
|
US5994063A
(en)
|
1995-06-23 |
1999-11-30 |
Metzker; Michael L. |
Substituted 4,4-difluoro-4-bora-3A,4A-diaza-s-indacene compounds for homogenous amplification/detection assays
|
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
|
HUP9602538A3
(en)
|
1995-09-18 |
1997-08-28 |
Sankyo Co |
New urea and amide derivatives having acat inhibitory activity, their preparation and their use
|
|
SE510846C2
(sv)
|
1995-11-06 |
1999-06-28 |
Moelnlycke Health Care Ab |
Innerförpackning för i en yttre förpackning sterilförpackade bukdukar
|
|
WO1997017329A1
(en)
|
1995-11-07 |
1997-05-15 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
|
|
EP0882715B1
(en)
|
1995-12-28 |
2003-04-23 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Novel n-(unsubstituted or substituted)-4-substituted-6-(unsubstituted or substituted)phenoxy-2-pyridinecarboxamides or thiocarboxamides, processes for producing the same, and herbicides
|
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US6103692A
(en)
|
1996-03-12 |
2000-08-15 |
The General Hospital Corporation |
Inhibiting protein interactions
|
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
US6211373B1
(en)
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
|
CA2202578A1
(en)
|
1996-04-15 |
1997-10-15 |
Mitsuru Shiraishi |
Hydroxypyridine derivatives, their production and use
|
|
TR199802136T2
(xx)
|
1996-04-23 |
2001-06-21 |
Vertex Pharmaceuticals Incorporated |
�MPDH enzimi inhibit�rleri olarak �re t�revleri.
|
|
US6232299B1
(en)
|
1996-05-01 |
2001-05-15 |
Eli Lilly And Company |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
|
|
JPH09301858A
(ja)
|
1996-05-13 |
1997-11-25 |
Senju Pharmaceut Co Ltd |
グルコン酸クロルヘキシジン安定化水性薬剤
|
|
CA2255858C
(en)
|
1996-05-24 |
2007-09-11 |
Neurosearch A/S |
Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
|
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
|
JP2000513360A
(ja)
|
1996-06-27 |
2000-10-10 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ―８レセプターアンタゴニスト
|
|
KR20000022273A
(ko)
|
1996-06-27 |
2000-04-25 |
스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 |
Il-8 수용체 길항제
|
|
CZ425598A3
(cs)
|
1996-06-27 |
1999-08-11 |
Smithkline Beecham Corporation |
Antagonista IL-8 receptoru
|
|
EP0907362A4
(en)
|
1996-06-27 |
1999-12-01 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
DE69722360T2
(de)
|
1996-06-29 |
2003-11-27 |
Samjin Pharm, Co. |
Piperazin-derivate und verfahren zu ihrer herstellung
|
|
US6117635A
(en)
|
1996-07-16 |
2000-09-12 |
Intergen Company |
Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
|
|
US6150415A
(en)
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
|
US5808080A
(en)
|
1996-09-05 |
1998-09-15 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
|
WO1998017207A1
(en)
|
1996-10-21 |
1998-04-30 |
Synthes Ag Chur |
Surgical prosthetic device
|
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
AU4988997A
(en)
|
1996-10-23 |
1998-05-15 |
Osteoscreen, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
JP2001503775A
(ja)
|
1996-11-15 |
2001-03-21 |
ザ ピコワー インスティテュート フォー メディカル リサーチ |
Ｔ細胞の活性化に関係する疾患を治療するために有用なグアニルヒドラゾン
|
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
|
AU4966497A
(en)
|
1996-11-18 |
1998-06-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
|
|
FR2755967B1
(fr)
|
1996-11-21 |
1999-01-29 |
Pf Medicament |
Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
|
|
US5929250A
(en)
|
1997-01-23 |
1999-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
WO1998032439A1
(en)
|
1997-01-23 |
1998-07-30 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
JP2001512445A
(ja)
|
1997-02-12 |
2001-08-21 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ−８レセプターアンタゴニスト
|
|
TR199902432T2
(xx)
|
1997-04-04 |
2000-01-21 |
Prizer Products Inc. |
Nikotinamid t�revleri.
|
|
US20020111495A1
(en)
|
1997-04-04 |
2002-08-15 |
Pfizer Inc. |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
|
|
DK0973735T3
(da)
|
1997-04-10 |
2003-06-23 |
Upjohn Co |
Polyaromatiske antivirale præparater
|
|
AU7080298A
(en)
|
1997-04-25 |
1998-11-24 |
Takeda Chemical Industries Ltd. |
Triazine derivatives, their production and agrochemical composition
|
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
|
PL336990A1
(en)
|
1997-05-22 |
2000-07-31 |
Searle & Co |
3(5)-heteroaryl group substituted pyrazoles as inhibitors of kinase p 38
|
|
AU7726898A
(en)
|
1997-05-22 |
1998-12-11 |
G.D. Searle & Co. |
Pyrazole derivatives as p38 kinase inhibitors
|
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
|
JP2002500650A
(ja)
|
1997-05-23 |
2002-01-08 |
バイエル、コーポレイション |
Ｒａｆキナーゼ阻害剤
|
|
DE69826695T2
(de)
|
1997-05-23 |
2006-02-02 |
Bayer Pharmaceuticals Corp., West Haven |
Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
|
|
US6344476B1
(en)
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
|
US6187799B1
(en)
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
|
US6150395A
(en)
|
1997-05-30 |
2000-11-21 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
|
US5985592A
(en)
|
1997-06-05 |
1999-11-16 |
Dalhousie University |
Uses for pentoxifylline or functional derivatives/metabolites thereof
|
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
|
EP1023066A4
(en)
|
1997-06-13 |
2001-05-23 |
Smithkline Beecham Corp |
NEW PYRAZOLE AND PYRAZOLINE SUBSTITUTED COMPOUND
|
|
CA2294076A1
(en)
|
1997-06-27 |
1999-01-07 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
6-phenoxypicolinic acid, alkylidenehydrazide derivatives, process for producing the same, and herbicide
|
|
US6093742A
(en)
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
|
US6525065B1
(en)
|
1997-06-30 |
2003-02-25 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
|
AUPP003197A0
(en)
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
|
WO1999020617A1
(en)
|
1997-10-21 |
1999-04-29 |
Active Biotech Ab |
Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
|
|
DE69835688T2
(de)
|
1997-10-31 |
2007-10-04 |
Aventis Pharma Ltd., West Malling |
Substituierte anilide
|
|
EP1028953A1
(en)
|
1997-11-03 |
2000-08-23 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
IL135176A0
(en)
|
1997-11-10 |
2001-05-20 |
Bristol Myers Squibb Co |
Benzothiazole derivatives and pharmaceutical compositions containing the same
|
|
US6018065A
(en)
|
1997-11-10 |
2000-01-25 |
Advanced Technology Materials, Inc. |
Method of fabricating iridium-based materials and structures on substrates, iridium source reagents therefor
|
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
|
WO1999028305A1
(en)
|
1997-12-01 |
1999-06-10 |
E.I. Du Pont De Nemours And Company |
Fungicidal cyclic amides
|
|
US6635421B1
(en)
|
1997-12-09 |
2003-10-21 |
Children's Medical Center Corporation |
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
|
|
US6174901B1
(en)
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
|
SK282727B6
(sk)
|
1997-12-19 |
2002-11-06 |
Slovakofarma, A. S. |
1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
|
|
EP1047418B1
(en)
|
1997-12-22 |
2005-07-27 |
Bayer Pharmaceuticals Corp. |
Inhibition of raf kinase using substituted heterocyclic ureas
|
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
|
US20120046290A1
(en)
*
|
1997-12-22 |
2012-02-23 |
Jacques Dumas |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
|
IL136737A0
(en)
|
1997-12-22 |
2001-06-14 |
Bayer Ag |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
US20070244120A1
(en)
*
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
|
DE69836563T2
(de)
|
1997-12-22 |
2007-05-16 |
Bayer Pharmaceuticals Corp., West Haven |
INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYL-SUBSTITUIERTEN HARNSTOFFEN
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
EP1449834A3
(en)
|
1997-12-22 |
2004-12-22 |
Bayer Corporation |
Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
|
|
DE69834842T2
(de)
|
1997-12-22 |
2007-05-10 |
Bayer Pharmaceuticals Corp., West Haven |
Hemmung von raf-kinase unter verwendung von aryl- und heteroarylsubstituierten heterocyclischen harnstoffen
|
|
ES2154253T3
(es)
|
1997-12-22 |
2012-01-27 |
Bayer Healthcare Llc |
Inhibición de la actividad de p38 cinasa usando ureas heterocíclicas sustituidas.
|
|
AU1712899A
(en)
|
1997-12-23 |
1999-07-12 |
Bristol-Myers Squibb Company |
7-deoxy-6-nitrogen substituted paclitaxels
|
|
WO1999033458A1
(en)
|
1997-12-25 |
1999-07-08 |
Daiichi Pharmaceutical Co., Ltd. |
Medicinal composition for percutaneous administration
|
|
GB9800575D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
US6221913B1
(en)
|
1998-01-21 |
2001-04-24 |
Zymogenetics, Inc. |
Dialkyl ureas as calcitonin mimetics
|
|
FR2774824B1
(fr)
|
1998-02-09 |
2000-04-28 |
Moving Magnet Tech |
Actionneur lineaire ameliore
|
|
WO1999042821A2
(en)
|
1998-02-18 |
1999-08-26 |
Theryte Limited |
Treating cancer
|
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
|
US6413773B1
(en)
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
|
US6667340B1
(en)
|
1998-06-26 |
2003-12-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of phosphatidyl myo-inositol cycle
|
|
US6352977B1
(en)
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
JP2002526482A
(ja)
|
1998-09-18 |
2002-08-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ｐ３８のインヒビター
|
|
US6383734B1
(en)
|
1998-09-30 |
2002-05-07 |
Advanced Research And Technology Institute, Inc. |
Method to determine inhibition of PAK3 activation of Raf-1
|
|
US6130053A
(en)
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
|
HUP0104302A3
(en)
|
1998-11-06 |
2002-11-28 |
Abbott Gmbh & Co Kg |
Inhibition of the formation of vascular hyperpermeability
|
|
AU2156600A
(en)
|
1998-11-25 |
2000-06-13 |
Cold Spring Harbor Laboratory |
Methods and reagents for increasing proliferative capacity and preventing replicative senescence
|
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
|
WO2000035455A1
(en)
|
1998-12-15 |
2000-06-22 |
Telik, Inc. |
Heteroaryl-aryl ureas as igf-1 receptor antagonists
|
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
|
US6331541B1
(en)
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
WO2000035454A1
(en)
|
1998-12-18 |
2000-06-22 |
Du Pont Pharmaceuticals Company |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
US6147107A
(en)
|
1998-12-20 |
2000-11-14 |
Virginia Commonwealth University |
Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
|
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
WO2000039116A1
(en)
|
1998-12-25 |
2000-07-06 |
Teikoku Hormone Mfg. Co., Ltd. |
Aminopyrazole derivatives
|
|
US6351764B1
(en)
|
1998-12-31 |
2002-02-26 |
Michael Voticky |
System and method for prioritizing communications messages
|
|
RU2319693C9
(ru)
|
1999-01-13 |
2008-08-20 |
Байер Копэрейшн |
Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
EP1140840B1
(en)
*
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US20020065296A1
(en)
*
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
|
ATE538794T1
(de)
|
1999-01-13 |
2012-01-15 |
Bayer Healthcare Llc |
Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
|
|
TWI284642B
(en)
|
1999-01-18 |
2007-08-01 |
Hoffmann La Roche |
Novel heterocyclic sulfonamides
|
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
JP3519368B2
(ja)
|
1999-01-22 |
2004-04-12 |
麒麟麦酒株式会社 |
キノリン誘導体およびキナゾリン誘導体
|
|
ES2226785T3
(es)
|
1999-02-12 |
2005-04-01 |
Smithkline Beecham Plc |
Derivados de fenilurea como antagonistas de los receptores de orexina.
|
|
EP1157026A1
(en)
|
1999-02-22 |
2001-11-28 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Polycyclo heterocyclic derivatives as antiinflammatory agents
|
|
PL350357A1
(en)
|
1999-03-12 |
2002-12-02 |
Boehringer Ingelheim Pharma |
Heterocyclic urea and related compounds useful as anti−inflammatory agents
|
|
DE60023853T2
(de)
|
1999-03-12 |
2006-05-24 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
|
|
ES2405316T3
(es)
|
1999-03-19 |
2013-05-30 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de la enzima IMPDH
|
|
UA72244C2
(en)
|
1999-03-26 |
2005-02-15 |
|
Aryl-substituted pyrazols, imidazols, oxazols, thiazols, pyrrols and their use
|
|
US6140124A
(en)
|
1999-04-06 |
2000-10-31 |
Isis Pharmaceuticals Inc. |
Antisense modulation of P38 mitogen activated protein kinase expression
|
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
|
DE60009480T2
(de)
|
1999-05-05 |
2005-09-01 |
Aventis Pharma Ltd., West Malling |
Harnstoffe als modulatoren der zelladhäsion
|
|
HK1047236A1
(zh)
|
1999-05-14 |
2003-02-14 |
Imclone Llc |
用表皮生长因子受体拮抗剂治疗难治的人肿瘤
|
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
|
DE19927835A1
(de)
|
1999-06-18 |
2000-12-21 |
Clariant Gmbh |
Verwendung von verbesserten Cyanpigmenten in elektrophotographischen Tonern und Entwicklern, Pulverlacken und Ink-Jet-Tinten
|
|
EP1200411B1
(en)
|
1999-07-09 |
2005-12-14 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Process for synthesis of heteroaryl-substituted urea compounds
|
|
US6958333B1
(en)
|
1999-07-26 |
2005-10-25 |
Banyu Pharmaceutical Co., Ltd. |
Biarylurea derivatives
|
|
WO2001009088A1
(en)
|
1999-07-28 |
2001-02-08 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
|
US6372933B1
(en)
|
1999-08-26 |
2002-04-16 |
Smithkline Beecham Corporation |
Process for preparing certain phenyl urea compounds
|
|
MXPA02003742A
(es)
|
1999-10-15 |
2003-10-14 |
Kampen Group Inc Van |
Tratamiento de tumores dermicos, verrugas e infecciones virales usando p. acnes muerto por calor.
|
|
US6420378B1
(en)
|
1999-10-15 |
2002-07-16 |
Supergen, Inc. |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
|
|
US6794393B1
(en)
|
1999-10-19 |
2004-09-21 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
JP4955171B2
(ja)
|
1999-11-16 |
2012-06-20 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症剤としての尿素誘導体
|
|
US8815517B2
(en)
*
|
1999-12-28 |
2014-08-26 |
Ribonomics, Inc. |
Methods for identifying functionally related genes and drug targets
|
|
MXPA02006086A
(es)
|
1999-12-29 |
2004-08-23 |
Wyeth Corp |
Inhibidores triciclicos de proteina-cinasas.
|
|
AU2951801A
(en)
*
|
2000-01-12 |
2001-07-24 |
Ventana Medical Systems, Inc. |
Method for quantitating a protein by image analysis
|
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
|
JP2003521543A
(ja)
|
2000-02-07 |
2003-07-15 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
２−ベンゾチアゾリル尿素誘導体およびそのプロテインキナーゼ阻害剤としての使用
|
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
US6658473B1
(en)
|
2000-02-25 |
2003-12-02 |
Sun Microsystems, Inc. |
Method and apparatus for distributing load in a computer environment
|
|
JP2003525248A
(ja)
|
2000-03-02 |
2003-08-26 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
血管内皮成長因子ｄを発現する癌の治療、スクリーニング、及び検出方法
|
|
GB0005357D0
(en)
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
|
JP2003525897A
(ja)
|
2000-03-06 |
2003-09-02 |
アストラゼネカ アクチボラグ |
治 療
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
|
US6390102B1
(en)
|
2000-07-14 |
2002-05-21 |
General Electric Company |
Silicone compositions for personal care products and method for making
|
|
EP1311277A4
(en)
|
2000-07-18 |
2004-08-25 |
Joslin Diabetes Center Inc |
METHODS OF FIBROSIS MODULATION
|
|
MXPA02012909A
(es)
|
2000-07-24 |
2004-05-05 |
Boehringer Ingelheim Pharma |
Formulaciones mejoradas de dosis oral de 1-(5-ter-butil -2-p-tiolil2h -pirazol-3 -il)-3-(4-2 (2-morfolin-4-il -etoxi) -naftalen -1-il) -urea.
|
|
PY0117895A
(es)
|
2000-07-31 |
2003-11-03 |
Pfizer Prod Inc |
Derivados de imidazol
|
|
EP1355933A2
(en)
|
2000-08-04 |
2003-10-29 |
Loma Linda University Medical Center |
Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative diseases
|
|
WO2002014281A1
(en)
|
2000-08-11 |
2002-02-21 |
Vertex Pharmaceuticals Incorporated |
Pyridine derivatives as inhibitors of p38
|
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
|
WO2002014338A1
(fr)
|
2000-08-17 |
2002-02-21 |
The Kitasato Institute |
Nouveaux derives de pseudoerythromycine
|
|
SK2002003A3
(en)
|
2000-08-31 |
2004-04-06 |
Pfizer Prod Inc |
Pyrazole derivatives and their use as protein kinase inhibitors
|
|
US20020055117A1
(en)
*
|
2000-09-20 |
2002-05-09 |
James Fett |
Methods for detecting prostate cancer
|
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
ATE419239T1
(de)
|
2000-10-20 |
2009-01-15 |
Eisai R&D Man Co Ltd |
Verfahren zur herstellung von 4-phenoxy chinolin derivaten
|
|
JP3768800B2
(ja)
|
2000-10-31 |
2006-04-19 |
キヤノン株式会社 |
画像形成装置
|
|
EP1345890A1
(en)
|
2000-11-17 |
2003-09-24 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
IL155820A0
(en)
|
2000-11-27 |
2003-12-23 |
Eric A Brill |
System, method and program for storing objects
|
|
CA2430065C
(en)
|
2000-11-28 |
2008-05-20 |
Pfizer Products Inc. |
Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
|
|
EP1341771A2
(en)
|
2000-11-29 |
2003-09-10 |
Glaxo Group Limited |
Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
|
|
DE60133781T2
(de)
|
2000-12-08 |
2009-06-25 |
Kyowa Hakko Kogyo Co., Ltd. |
Orale zubereitungen mit juckreizlindernder oder antipruritischer wirkung
|
|
CN1492874A
(zh)
|
2000-12-21 |
2004-04-28 |
|
大环内酯
|
|
KR100362390B1
(ko)
|
2000-12-29 |
2002-11-23 |
삼성전자 주식회사 |
화상형성장치의 현상기-토너 카트리지 조립체
|
|
US7235576B1
(en)
*
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
EP1360173A2
(en)
|
2001-01-25 |
2003-11-12 |
Guilford Pharmaceuticals Inc. |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
|
FR2820136A1
(fr)
|
2001-01-26 |
2002-08-02 |
Aventis Pharma Sa |
Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
|
WO2002059081A2
(en)
|
2001-01-26 |
2002-08-01 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
|
EP3342411B1
(en)
|
2001-02-19 |
2019-08-21 |
Novartis Pharma AG |
Rapamycin derivative for treating pancreas cancer
|
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
|
JP2004528311A
(ja)
|
2001-03-07 |
2004-09-16 |
テリック，インコーポレイテッド |
Ｆａｓ媒介アポトーシスの刺激剤としての置換ジアリールウレア
|
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
|
PE20020958A1
(es)
|
2001-03-23 |
2002-11-14 |
Bayer Corp |
Inhibidores de la rho-quinasa
|
|
EP1383532B1
(en)
|
2001-04-02 |
2011-05-04 |
Genentech, Inc. |
Combination therapy
|
|
CA2490819A1
(en)
|
2001-04-13 |
2002-10-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
MXPA03009000A
(es)
|
2001-04-13 |
2004-02-12 |
Boehringer Ingelheim Pharma |
Compuestos benzo-fusionados 1,4-disustituidos.
|
|
US20030207914A1
(en)
|
2001-04-20 |
2003-11-06 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
CA2443950C
(en)
|
2001-04-20 |
2011-10-18 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
WO2002088090A2
(en)
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Pyrazole derived kinase inhibitors
|
|
CA2445003A1
(en)
|
2001-05-16 |
2002-11-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Diarylurea derivatives useful as anti-inflammatory agents
|
|
JP2004535185A
(ja)
*
|
2001-05-25 |
2004-11-25 |
イミュネックス・コーポレーション |
アトラクチン／マホガニー様ポリペプチド、ポリヌクレオチド、抗体、およびそれらを使用する方法
|
|
WO2003004523A1
(en)
|
2001-07-02 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human citron rho/rac-interacting kinase
|
|
ES2284887T3
(es)
|
2001-07-11 |
2007-11-16 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Metodos para tratar enfermedades transmitidas por citocinas.
|
|
ATE345130T1
(de)
|
2001-12-03 |
2006-12-15 |
Bayer Pharmaceuticals Corp |
Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen
|
|
AU2002365899B2
(en)
|
2001-12-04 |
2007-09-13 |
Onyx Pharmaceuticals, Inc. |
RAF-MEK-ERK pathway inhibitors to treat cancer
|
|
BRPI0214840B8
(pt)
|
2001-12-21 |
2021-05-25 |
The Wellcome Trust |
métodos para a detecção de mutações oncogênicas humanas, métodos automatizados para detectar uma mutação e método e ensaio para identificar um ou mais compostos tendo atividade anti-proliferativa
|
|
AU2002356323A1
(en)
|
2001-12-24 |
2003-07-30 |
Catalyst Biomedica Limited |
Cancer-specific mutants of b-raf genes and uses thereof
|
|
US20040096855A1
(en)
|
2001-12-24 |
2004-05-20 |
Michael Stratton |
Genes
|
|
US20080108672A1
(en)
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
AU2003207961A1
(en)
|
2002-01-16 |
2003-07-30 |
Ramot At Tel Aviv University Ltd. |
Compositions and their use for enhancing and inhibiting fertilization
|
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
|
US7838541B2
(en)
|
2002-02-11 |
2010-11-23 |
Bayer Healthcare, Llc |
Aryl ureas with angiogenesis inhibiting activity
|
|
US20030216396A1
(en)
|
2002-02-11 |
2003-11-20 |
Bayer Corporation |
Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
|
|
US20040023961A1
(en)
|
2002-02-11 |
2004-02-05 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenisis inhibiting activity
|
|
PT1580188E
(pt)
|
2002-02-11 |
2012-01-25 |
Bayer Healthcare Llc |
Aril-ureias como inibidores de cinases
|
|
US7645878B2
(en)
*
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
|
US7071216B2
(en)
|
2002-03-29 |
2006-07-04 |
Chiron Corporation |
Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
|
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
|
DE10221524A1
(de)
|
2002-05-14 |
2003-12-04 |
Kmb Produktions Ag Felben |
Verfahren und Vorrichtung zum Herstellen von Verzehrgütern
|
|
WO2003097854A2
(en)
|
2002-05-17 |
2003-11-27 |
Sugen, Inc. |
Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
|
|
AR037647A1
(es)
|
2002-05-29 |
2004-12-01 |
Novartis Ag |
Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
|
|
JP2005538975A
(ja)
|
2002-07-03 |
2005-12-22 |
アステックス テクノロジー リミテッド |
ｐ３８ＭＡＰキナーゼ阻害薬としての３−（ヘテロ）アリールメトキシピリジン類およびそれらの類縁体
|
|
US7476683B2
(en)
|
2002-08-27 |
2009-01-13 |
Merck Patent Gmbh |
Glycinamide derivatives as raf-kinase inhibitors
|
|
EP1562905A2
(en)
|
2002-10-24 |
2005-08-17 |
MERCK PATENT GmbH |
Methylene urea derivatives as raf-kinase inhibitors
|
|
CA2504933C
(en)
|
2002-11-06 |
2012-10-16 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for treating cancer using proteasome inhibitors
|
|
NZ539850A
(en)
|
2002-11-15 |
2008-05-30 |
Novartis Ag |
Drug delivery device or system comprising pimecromilus
|
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
|
US20030232400A1
(en)
|
2002-12-20 |
2003-12-18 |
Susan Radka |
Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
JP4927533B2
(ja)
|
2003-02-28 |
2012-05-09 |
ニッポネックス インコーポレイテッド |
癌その他の疾患の治療に有用な置換ピリジン誘導体
|
|
UY28213A1
(es)
|
2003-02-28 |
2004-09-30 |
Bayer Pharmaceuticals Corp |
Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
|
|
MXPA05009104A
(es)
*
|
2003-02-28 |
2006-05-31 |
Bayer Pharmaceuticals Corp |
Derivados de urea biciclica novedosa utiles en el tratamiento del cancer y otros trastornos.
|
|
ATE489379T1
(de)
|
2003-02-28 |
2010-12-15 |
Bayer Healthcare Llc |
2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
|
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
|
MXPA05010020A
(es)
|
2003-03-24 |
2005-11-17 |
Merck Patent Gmbh |
Derivados de oxamida.
|
|
WO2004084889A1
(en)
|
2003-03-28 |
2004-10-07 |
Pfizer Inc. |
Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons
|
|
US6896863B2
(en)
|
2003-04-01 |
2005-05-24 |
E. I. Du Pont De Nemours And Company |
Sodium cyanide process
|
|
WO2004113274A2
(en)
|
2003-05-20 |
2004-12-29 |
Bayer Pharmaceuticals Corporation |
Diaryl ureas with kinase inhibiting activity
|
|
CA2527573A1
(en)
|
2003-06-05 |
2004-12-16 |
Warner-Lambert Company Llc |
Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
|
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
|
JP4750701B2
(ja)
|
2003-07-07 |
2011-08-17 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
マロンアミド誘導体
|
|
CA2531454C
(en)
|
2003-07-08 |
2011-10-25 |
Novartis Ag |
Use of rapamycin and rapamycin derivatives for the treatment of bone loss
|
|
EP1648900A4
(en)
|
2003-07-11 |
2010-02-10 |
Ariad Pharma Inc |
PHOSPHORUS MACROCYCLES
|
|
EP1643991B1
(en)
|
2003-07-11 |
2014-03-12 |
Merck Patent GmbH |
Benzimidazole carboxamides as raf kinase inhibitors
|
|
CA2531859C
(en)
|
2003-07-11 |
2013-08-06 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Benzimidazole derivatives as raf kinase inhibitors
|
|
WO2005009367A2
(en)
|
2003-07-17 |
2005-02-03 |
Ambit Biosciences Corporation |
Treatment of diseases with kinase inhibitors
|
|
RS52625B
(sr)
|
2003-07-23 |
2013-06-28 |
Bayer Healthcare Llc |
Fluoro supstituisana omega-karboksiaril difenil urea za lečenje i prevenciju bolesti i stanja bolesti
|
|
TW200523262A
(en)
|
2003-07-29 |
2005-07-16 |
Smithkline Beecham Corp |
Inhibitors of AKT activity
|
|
DE10334663A1
(de)
|
2003-07-30 |
2005-03-10 |
Merck Patent Gmbh |
Harnstoffderivate
|
|
AU2004264948A1
(en)
|
2003-08-15 |
2005-02-24 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Multifactorial assay for cancer detection
|
|
EP1682181A2
(en)
|
2003-09-23 |
2006-07-26 |
Novartis AG |
Combination of a vegf receptor inhibitor with a chemotherapeutic agent
|
|
DE10344223A1
(de)
|
2003-09-24 |
2005-04-21 |
Merck Patent Gmbh |
1,3-Benzoxazolylderivate als Kinase-Inhibitoren
|
|
US20080045546A1
(en)
|
2003-10-15 |
2008-02-21 |
Axel Bouchon |
Tetradydro-Naphthalene And Urea Derivatives
|
|
MXPA06003607A
(es)
|
2003-10-16 |
2006-06-05 |
Chiron Corp |
Quinazolinas, quinoxalinas, quinolinas e isoquinolinas 2.6-disubstituidas como inhibidores de la cinasa raf para el tratamiento del cancer.
|
|
DE602004021838D1
(de)
|
2003-10-16 |
2009-08-13 |
Novartis Vaccines & Diagnostic |
Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
|
|
DE10349587A1
(de)
|
2003-10-24 |
2005-05-25 |
Merck Patent Gmbh |
Benzimidazolylderivate
|
|
CA2545711A1
(en)
|
2003-11-13 |
2005-06-02 |
Ambit Biosciences Corporation |
Urea derivatives as kinase modulators
|
|
DE10352979A1
(de)
|
2003-11-13 |
2005-06-09 |
Merck Patent Gmbh |
Pyridopyrimidinone
|
|
DE10354060A1
(de)
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
|
JP5006651B2
(ja)
|
2003-12-05 |
2012-08-22 |
ブリストル−マイヤーズ スクウィブ カンパニー |
２型血管内皮増殖因子受容体の阻害剤
|
|
ATE447957T1
(de)
|
2003-12-09 |
2009-11-15 |
Us Gov Health & Human Serv |
Verfahren zur unterdrückung einer immunantwort oder zur behandlung von proliferativen erkrankungen
|
|
AU2004299174A1
(en)
|
2003-12-10 |
2005-06-30 |
Merck Patent Gmbh |
Diacylhydrazine derivatives
|
|
US20070134670A1
(en)
|
2003-12-12 |
2007-06-14 |
Bayer Pharmaceuticals Corporation |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
|
AU2005211448A1
(en)
|
2004-01-30 |
2005-08-18 |
Merck Patent Gmbh |
Bisarylurea derivatives
|
|
MXPA06010667A
(es)
|
2004-03-19 |
2007-07-04 |
Penn State Res Found |
Metodos combinatorios y composiciones para el tratamiento de melanoma.
|
|
ATE517885T1
(de)
|
2004-04-30 |
2011-08-15 |
Bayer Healthcare Llc |
Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs
|
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
|
JP5128948B2
(ja)
*
|
2004-08-27 |
2013-01-23 |
ニッポネックス インコーポレイテッド |
癌の治療のための新規な薬剤組成物
|
|
ES2368930T3
(es)
|
2004-09-06 |
2011-11-23 |
Bayer Pharma Aktiengesellschaft |
Pirazolopirimidinas como inhibidores de proteína cinasa b (akt).
|
|
NZ554119A
(en)
|
2004-09-29 |
2010-07-30 |
Bayer Schering Pharma Ag |
Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide
|
|
KR101381454B1
(ko)
*
|
2004-09-29 |
2014-04-04 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
열역학적으로 안정한 형태의 ｂａｙ 43-9006 토실레이트
|
|
WO2006076592A1
(en)
|
2005-01-14 |
2006-07-20 |
Cgi Pharmaceuticals, Inc. |
1,3 substituted diaryl ureas as modulators of kinase activity
|
|
KR101335932B1
(ko)
|
2005-03-07 |
2013-12-04 |
바이엘 헬스케어 엘엘씨 |
암의 치료를 위한 오메가-카르복시아릴 치환된 디페닐우레아를 포함하는 제약 조성물
|
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
|
RU2007148266A
(ru)
|
2005-05-27 |
2009-07-10 |
Байер ХельсКер АГ (DE) |
Комбинированная терапия с использованием соединения диарилмочевины и ингибиторов pi3, akt-киназы или mtor (рапамицины) для лечения рака
|
|
WO2006125539A2
(en)
|
2005-05-27 |
2006-11-30 |
Bayer Healthcare Ag |
Combination therapy comprising diaryl ureas for treating diseases
|
|
WO2007015947A2
(en)
|
2005-07-29 |
2007-02-08 |
Bayer Healthcare Llc |
Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
|
|
WO2007021860A2
(en)
|
2005-08-11 |
2007-02-22 |
Bayer Healthcare Llc |
QUANTITATIVE ASSAYS FOR PDGFR-β IN BODY FLUIDS
|
|
AU2006298881A1
(en)
|
2005-09-21 |
2007-04-12 |
4Sc Ag |
Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
|
|
ES2381962T3
(es)
|
2005-09-21 |
2012-06-04 |
4Sc Ag |
Nuevos sulfonilpirroles como inhibidores de las HDAC
|
|
CN101506351A
(zh)
|
2005-10-21 |
2009-08-12 |
拜尔健康护理有限责任公司 |
用于癌症预测和预后及监测癌症治疗的方法
|
|
WO2007053573A2
(en)
|
2005-10-31 |
2007-05-10 |
Bayer Pharmaceuticals Corporation |
Treatment of cancer with sorafenib
|
|
US8329408B2
(en)
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
|
WO2007053574A2
(en)
*
|
2005-10-31 |
2007-05-10 |
Bayer Pharmaceuticals Corporation |
Combinations comprising sorafenib and interferon for the treatment of cancer
|
|
WO2007056012A2
(en)
|
2005-11-02 |
2007-05-18 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
|
US20080311601A1
(en)
|
2005-11-02 |
2008-12-18 |
Elting James J |
Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
|
|
EP1948176B1
(en)
|
2005-11-10 |
2011-01-05 |
Bayer Schering Pharma Aktiengesellschaft |
Diaryl ureas for treating pulmonary hypertension
|
|
KR20080067000A
(ko)
|
2005-11-10 |
2008-07-17 |
바이엘 헬스케어 아게 |
폐 고혈압을 치료하기 위한 디아릴 우레아
|
|
WO2007059154A2
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Healthcare Llc |
Treatment of cancers with acquired resistance to kit inhibitors
|
|
WO2007059155A1
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Treatment of cancers having resistance to chemotherapeutic agents
|
|
KR20080073745A
(ko)
|
2005-11-14 |
2008-08-11 |
바이엘 헬스케어 엘엘씨 |
암의 예측 및 예후 방법, 및 암 치료 요법을 모니터하는방법
|
|
JP2009518298A
(ja)
*
|
2005-12-01 |
2009-05-07 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
癌治療に有用な尿素化合物
|
|
US20090227637A1
(en)
|
2005-12-15 |
2009-09-10 |
Olaf Weber |
Diaryl ureas for treating virus infections
|
|
JP2009519265A
(ja)
*
|
2005-12-15 |
2009-05-14 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
ウイルス感染を処置するためのジアリールウレア
|
|
JP2009524585A
(ja)
*
|
2005-12-15 |
2009-07-02 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
ウイルス感染を処置するためのジアリールウレア
|
|
ES2480440T3
(es)
*
|
2005-12-21 |
2014-07-28 |
Bayer Intellectual Property Gmbh |
Derivados sustituidos de pirimidina útiles en el tratamiento del cáncer y de otros trastornos
|
|
US20090197922A1
(en)
|
2006-01-24 |
2009-08-06 |
The University Of Chicago |
Compositions and methods for treating pulmonary hypertension
|
|
EA015151B1
(ru)
|
2006-02-22 |
2011-06-30 |
4ЭсЦэ АГ |
Индолопиридины в качестве модуляторов кинезина eg5
|
|
JP5349056B2
(ja)
|
2006-02-22 |
2013-11-20 |
４エスツェー アクチェンゲゼルシャフト |
Ｅｇ５キネシンモジュレーターとしてのインドロピリジン類
|
|
US7908091B2
(en)
|
2006-03-17 |
2011-03-15 |
Prometheus Laboratories Inc. |
Methods of predicting and monitoring tyrosine kinase inhibitor therapy
|
|
EP2002264A2
(en)
|
2006-03-31 |
2008-12-17 |
Bayer HealthCare LLC |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
|
US20080045589A1
(en)
|
2006-05-26 |
2008-02-21 |
Susan Kelley |
Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
|
|
AR062927A1
(es)
*
|
2006-10-11 |
2008-12-17 |
Bayer Healthcare Ag |
4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
|
|
CA2667720A1
(en)
|
2006-11-09 |
2008-05-15 |
Abbott Gmbh & Co. Kg. |
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
|
|
CA2668748A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Bayer Schering Pharma Aktiengesellschaft |
Polymorph iii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
|
|
WO2008058644A1
(en)
*
|
2006-11-14 |
2008-05-22 |
Bayer Schering Pharma Aktiengesellschaft |
Polymorph ii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
|
|
EP2111401B1
(en)
|
2006-12-20 |
2011-02-16 |
Bayer HealthCare, LLC |
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino]-3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
|
|
US20100150863A1
(en)
*
|
2006-12-20 |
2010-06-17 |
Bayer Pharmaceuticals Corporation |
Hydroxy methyl phenyl pyrazolyl urea compound useful in treatment of cancer
|
|
EP2129376B1
(en)
*
|
2007-01-19 |
2013-07-24 |
Bayer HealthCare LLC |
Treatment of cancers with acquired resistance to KIT inhibitors
|
|
CA2675979A1
(en)
*
|
2007-01-19 |
2008-07-24 |
Bayer Healthcare Llc |
Treatment of cancers having resistance to chemotherapeutic agents
|
|
CA2698795C
(en)
|
2007-09-10 |
2016-04-19 |
Cipla Limited |
Process for the preparation of a raf kinase inhibitor and intermediates for use in the process
|
|
WO2009054004A2
(en)
|
2007-10-22 |
2009-04-30 |
Natco Pharma Limited |
Process for the preparation of sorafenib
|
|
FR2929509B1
(fr)
*
|
2008-04-02 |
2011-01-21 |
Lvmh Rech |
L'utilisation de glycosides d'alkyle ou de melanges de glycosides d'alkyle en tant qu'agents destines a inhiber la croissance microbienne, et compositions contenant lesdits glycosides d'alkyle.
|
|
EP2296641A1
(en)
*
|
2008-06-25 |
2011-03-23 |
Bayer Schering Pharma Aktiengesellschaft |
Diaryl urea for treating heart failure
|
|
JP5439494B2
(ja)
*
|
2008-10-21 |
2014-03-12 |
バイエル ヘルスケア エルエルシー |
肝細胞癌と関連するシグネチャ遺伝子の同定
|
|
JP5753785B2
(ja)
|
2008-11-07 |
2015-07-22 |
ノバベイ・ファーマシューティカルズ・インコーポレイテッドＮｏｖａｂａｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
抗菌オキサゾリジノン、ヒダントインおよびイミダゾリジノン組成物
|
|
JP5821626B2
(ja)
|
2011-12-27 |
2015-11-24 |
富士ゼロックス株式会社 |
画像形成装置及びプログラム
|